Separating the rash from the chaff: novel clinical decision support deployed during the mpox outbreak.
Jacob E LazarusChloe V GreenMichelle S JerryLindsay GermaineDustin S McEvoyCaitlin M DugdaleKristen M HysellRebecca L CraigMolly L ParasHoward M HellerKevin L ArdJohn S AlbinHang LeeErica S ShenoyPublished in: Infection control and hospital epidemiology (2024)
A clinical decision support system, EvalMpox, was developed to apply person under investigation (PUI) criteria for patients presenting with rash and to recommend testing for PUIs. Of 668 patients evaluated, an EvalMpox recommendation for testing had a positive predictive value of 35% and a negative predictive value of 99% for a positive mpox test.